Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

720 ARTÍCULOS , VIENDO DEL 346 AL 360

A systematic review of the efficacy and safety of anti-amyloid beta monoclonal antibodies in treatment of Alzheimer's disease

Chhabra A, Solanki S, Saravanabawan P, Venkiteswaran A, Nimmathota N, Modi NM.

Expert Opin Biol Ther. 2024 Nov;24(11):1261-1269. doi: 10.1080/14712598.2024.2416947. Epub 2024 Nov 12.

Surface engineered nano architectonics: An evolving paradigm for tackling Alzheimer's disease

Negi M, Amulya E, Phatale V, Abraham N, Hedaoo A, Srinivasarao DA, Srivastava S.

Life Sci. 2024 Dec 1;358:123155. doi: 10.1016/j.lfs.2024.123155. Epub 2024 Oct 19.

The potential role of transcription factor sterol regulatory element binding proteins (SREBPs) in Alzheimer's disease

Liu S, Li X, Fan P, Gu Y, Yang A, Wang W, Zhou L, Chen H, Zheng F, Lin J, Xu Z, Zhao Q.

Biomed Pharmacother. 2024 Nov;180:117575. doi: 10.1016/j.biopha.2024.117575. Epub 2024 Oct 22.

Preclinical and first-in-human evaluation of AL002, a novel TREM2 agonistic antibody for Alzheimer's disease

Long H, Simmons A, Mayorga A, Burgess B, Nguyen T, Budda B, Rychkova A, Rhinn H, Tassi I, Ward M, Yeh F, Schwabe T, Paul R, Kenkare-Mitra S, Rosenthal A.

Alzheimers Res Ther. 2024 Oct 23;16(1):235. doi: 10.1186/s13195-024-01599-1.

Olive Oil Industry By-Products as a Novel Source of Biophenols with a Promising Role in Alzheimer Disease Prevention

Gonçalves M, Costa M, Paiva-Martins F, Silva P.

Molecules. 2024 Oct 12;29(20):4841. doi: 10.3390/molecules29204841.

Role of Apolipoprotein E in Alzheimer's Disease Pathogenesis, Prognosis and Treatment

Reiss AB, Housny M, Gulkarov S, Hossain T, Locke B, Srivastava A, Pinkhasov A, Gomolin IH, Wisniewski T, De Leon J.

Discov Med. 2024 Oct;36(189):1917-1932. doi: 10.24976/Discov.Med.202436189.179.

Plasma exchange with albumin replacement for Alzheimer's disease treatment induced changes in serum and cerebrospinal fluid inflammatory mediator levels

Gonzalo R, Minguet C, Ortiz AM, Bravo MI, López OL, Boada M, Ruiz A, Costa M.

Ann Clin Transl Neurol. 2024 Dec;11(12):3280-3291. doi: 10.1002/acn3.52235. Epub 2024 Oct 30.

Indole-based COX-2 inhibitors: A decade of advances in inflammation, cancer, and Alzheimer's therapy

Shah M, Parmar R, Patel K, Nagani A.

Bioorg Chem. 2024 Dec;153:107931. doi: 10.1016/j.bioorg.2024.107931. Epub 2024 Oct 29.

A Comprehensive Analysis on Galantamine Based Hybrids for the Management of Alzheimer's Disease

Singh YP, Prasad S, Kumar H.

Chem Biol Drug Des. 2024 Oct;104(5):e70004. doi: 10.1111/cbdd.70004.

Keep neuroinflammation in mind when addressing Alzheimer's disease: A microglia perspective

Gessi S, Mirandola P, Merighi S.

J Alzheimers Dis. 2024 Nov;102(2):314-316. doi: 10.1177/13872877241290693. Epub 2024 Nov 3.

Neurocognitive effects of proanthocyanidin in Alzheimer's disease: a systematic review of preclinical evidence

Reshma A, Subramanian A, Kumarasamy V, Tamilanban T, Sekar M, Gan SH, Subramaniyan V, Wong LS, Rani NNIM, Wu YS.

Braz J Med Biol Res. 2024 Nov 4;57:e13587. doi: 10.1590/1414-431X2024e13587. eCollection 2024.

Therapeutic role of NLRP3 inflammasome inhibitors against Alzheimer's disease

Tantra T, Rahaman T A A, Nandini, Chaudhary S.

Bioorg Chem. 2024 Dec;153:107912. doi: 10.1016/j.bioorg.2024.107912. Epub 2024 Oct 23.

Prevention and Treatment of Alzheimer's Disease Via the Regulation of the Gut Microbiota With Traditional Chinese Medicine

Long J, Zhang J, Zeng X, Wang M, Wang N.

CNS Neurosci Ther. 2024 Nov;30(11):e70101. doi: 10.1111/cns.70101.

Redox regulation, protein S-nitrosylation, and synapse loss in Alzheimer's and related dementias

Oh CK, Nakamura T, Zhang X, Lipton SA.

Neuron. 2024 Dec 4;112(23):3823-3850. doi: 10.1016/j.neuron.2024.10.013. Epub 2024 Nov 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias